Cidara Therapeutics to Present at the Stifel Healthcare Conference
Cidara Therapeutics (NASDAQ: CDTX) has announced that Jeffrey Stein, Ph.D., President and CEO, will present at the Stifel Healthcare Conference on November 15, 2022, at 4:45 PM ET. The presentation will showcase Cidara's developments in long-acting therapeutics aimed at improving patient care. The event will be available for on-demand viewing on the company’s website following the presentation. Cidara focuses on innovative treatments including the Phase 3 antifungal candidate, rezafungin, and drug-Fc conjugates from its proprietary Cloudbreak platform.
- None.
- None.
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, will present at the Stifel Healthcare Conference.
| Presentation Information: | |
| Date: | Tuesday, November 15, 2022 |
| Time: | 4:45 PM ET |
| Webcast: | https://wsw.com/webcast/stifel74/cdtx/2101782 |
Cidara’s presentation will be available on-demand from the above date/time in the Investors section on the Company’s website at www.cidara.com. The replay of the presentation will be available for 90 days.
About Cidara Therapeutics
Cidara is developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases. The Company’s portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to drug-Fc conjugates (DFCs) targeting viral and oncology diseases from Cidara’s proprietary Cloudbreak® platform. Cidara is headquartered in San Diego, California. For more information, please visit www.cidara.com.
INVESTOR CONTACT:
Brian Ritchie
LifeSci Advisors
(212) 915-2578
britchie@lifesciadvisors.com
MEDIA CONTACT:
Patrick Bursey
LifeSci Communications
(203) 430-9545
pbursey@lifescicomms.com
FAQ
When will Cidara Therapeutics present at the Stifel Healthcare Conference?
Who is presenting for Cidara Therapeutics at the conference?
How can I access the Cidara Therapeutics presentation?
What is the focus of Cidara Therapeutics' presentation at the conference?
What is Cidara Therapeutics' lead product candidate?
